POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TUF_B_AZ1B503_1 (DIAMINOPIMELATE DECARBOXYLASE)	4dtg	HUMANIZED RECOMBINANT FAB FRAGMENT, FAB 2021, OF A MURINE ANTIBODY, HEAVY CHAIN TISSUE FACTOR PATHWAY INHIBITOR (Homo sapiens)	4 / 6	GLU K  11 SER H  54 TYR H  59 TYR H  57	PGE  H 304 ( 3.5A) None None None	1.21A	9.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TUF_B_AZ1B503_1 (DIAMINOPIMELATE DECARBOXYLASE)	4n2c	PROTEIN-ARGININE DEIMINASE TYPE-2 (Homo sapiens)	4 / 6	GLU A 474 SER A 404 ARG A 441 ARG A 580	None	1.29A	19.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	1gzk	RAC-BETA SERINE/THREONINE PROTEIN KINASE (Homo sapiens)	4 / 7	GLY A 159 GLY A 161 LYS A 181 LEU A 183	None	0.37A	39.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	1kfu	M-CALPAIN LARGE SUBUNIT (Homo sapiens)	4 / 7	GLY L 198 GLY L 203 PHE L 204 LEU L 338	None	0.81A	19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	1kt8	BRANCHED-CHAIN AMINO ACID AMINOTRANSFERASE, MITOCHONDRIAL (Homo sapiens)	4 / 7	GLY A 312 SER A 311 LEU A 349 GLU A  76	ILP  A 400 (-3.5A) None None None	0.79A	22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	1lm7	SUBDOMAIN OF DESMOPLAKIN CARBOXY-TERMINAL DOMAIN (DPCT) (Homo sapiens)	4 / 7	GLY A2319 GLY A2322 PHE A2325 LEU A2292	None	0.87A	22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	1tg6	PUTATIVE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT (Homo sapiens)	4 / 7	GLY A  33 GLY A  67 SER A  97 LEU A 102	None	0.83A	22.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	1zrz	PROTEIN KINASE C, IOTA (Homo sapiens)	4 / 7	GLY A 252 GLY A 254 SER A 255 LYS A 274	BI1  A1000 (-3.6A) None None BI1  A1000 (-3.5A)	0.75A	34.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	2abj	BRANCHED-CHAIN-AMINO -ACID AMINOTRANSFERASE, CYTOSOLIC (Homo sapiens)	4 / 7	GLY A 330 SER A 329 LEU A 367 GLU A  94	CBC  A1401 ( 3.4A) None None None	0.75A	21.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	2i0e	PROTEIN KINASE C-BETA II (Homo sapiens)	4 / 7	GLY A 349 GLY A 351 LYS A 371 LEU A 373	PDS  A 901 ( 3.7A) None PDS  A 901 ( 4.5A) None	0.87A	36.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	2jam	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE TYPE 1G (Homo sapiens)	4 / 7	GLY A  30 GLY A  32 PHE A  34 LYS A  52	None None None EDO  A1304 ( 2.9A)	0.49A	30.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	2v55	RHO-ASSOCIATED PROTEIN KINASE 1 (Homo sapiens)	4 / 7	GLY A  83 GLY A  85 LYS A 105 LEU A 107	ANP  A1480 ( 4.3A) ANP  A1480 ( 3.8A) ANP  A1480 (-3.4A) None	0.53A	35.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	2wtk	SERINE/THREONINE-PRO TEIN KINASE 11 (Homo sapiens)	4 / 7	GLY C  56 GLY C  58 SER C  59 GLU C 138	ANP  C   2 (-3.3A) ANP  C   2 (-3.0A) None ANP  C   2 (-4.1A)	0.74A	28.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	2wtk	SERINE/THREONINE-PRO TEIN KINASE 11 (Homo sapiens)	5 / 7	GLY C  56 GLY C  58 SER C  59 LYS C  78 LEU C  80	ANP  C   2 (-3.3A) ANP  C   2 (-3.0A) None ANP  C   2 (-3.6A) None	1.13A	28.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	2z8c	INSULIN RECEPTOR (Homo sapiens)	4 / 7	GLY A1003 GLY A1005 SER A1006 PHE A1007	S91  A   1 ( 3.9A) None None None	0.57A	23.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	4 / 7	GLY A  20 GLY A  22 LYS A  42 GLU A 100	4RB  A 401 (-3.6A) None 4RB  A 401 ( 2.8A) 4RB  A 401 (-3.8A)	0.52A	26.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	3gqc	DNA REPAIR PROTEIN REV1 (Homo sapiens)	4 / 7	GLY A 609 GLY A 611 SER A 612 LEU A 615	None	0.71A	20.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	3hdn	SERINE/THREONINE-PRO TEIN KINASE SGK1 (Homo sapiens)	5 / 7	GLY A 105 GLY A 107 SER A 108 PHE A 109 GLU A 183	None GMG  A   1 (-3.3A) None None None	1.00A	38.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	3lm5	SERINE/THREONINE-PRO TEIN KINASE 17B (Homo sapiens)	4 / 7	GLY A  40 GLY A  42 LEU A  64 GLU A 117	None	0.43A	27.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 7	GLY A 695 GLY A 697 LYS A 721 LEU A 723	ITI  A   1 ( 4.8A) None ITI  A   1 (-2.6A) None	0.77A	22.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	3mvj	CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	5 / 7	GLY A  50 GLY A  52 SER A  53 LEU A  74 GLU A 127	XFE  A 351 ( 4.0A) None None None XFE  A 351 (-4.2A)	1.12A	94.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	3mvj	CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	5 / 7	GLY A  50 GLY A  52 SER A  53 PHE A  54 GLU A 127	XFE  A 351 ( 4.0A) None None None XFE  A 351 (-4.2A)	1.19A	94.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	3mvj	CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	5 / 7	GLY A  50 SER A  53 LYS A  72 LEU A  74 GLU A 127	XFE  A 351 ( 4.0A) None None None XFE  A 351 (-4.2A)	1.13A	94.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	3nuu	PKB-LIKE (Homo sapiens)	5 / 7	GLY A  89 GLY A  91 SER A  92 LEU A 113 GLU A 166	JOZ  A 361 ( 4.3A) SO4  A   5 ( 4.4A) SO4  A   5 (-4.4A) None None	1.34A	37.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	3nuu	PKB-LIKE (Homo sapiens)	5 / 7	GLY A  89 SER A  92 LYS A 111 LEU A 113 GLU A 166	JOZ  A 361 ( 4.3A) SO4  A   5 (-4.4A) SO4  A   5 (-2.8A) None None	1.30A	37.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 7	GLY A 157 GLY A 159 LYS A 179 LEU A 181	GLY  A 157 ( 0.0A) GLY  A 159 ( 0.0A) LYS  A 179 ( 0.0A) LEU  A 181 ( 0.6A)	0.18A	34.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	1gng	GLYCOGEN SYNTHASE KINASE-3 BETA (Homo sapiens)	5 / 7	GLY A  63 GLY A  65 SER A  66 GLY A  68 VAL A  70	None	0.64A	23.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	1gzk	RAC-BETA SERINE/THREONINE PROTEIN KINASE (Homo sapiens)	5 / 7	GLY A 159 GLY A 161 GLY A 164 VAL A 166 LEU A 183	None	0.32A	39.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	1rjb	FL CYTOKINE RECEPTOR (Homo sapiens)	4 / 7	GLY A 617 GLY A 619 GLY A 622 VAL A 624	None	0.30A	24.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 7	GLY A 596 GLY A 598 GLY A 601 VAL A 603	None None None STI  A   3 ( 4.6A)	0.34A	24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	1tki	TITIN (Homo sapiens)	4 / 7	GLY A  31 GLY A  33 GLY A  36 VAL A  38	None	0.37A	25.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	1u59	TYROSINE-PROTEIN KINASE ZAP-70 (Homo sapiens)	4 / 7	GLY A 345 GLY A 347 GLY A 350 VAL A 352	STU  A 100 (-3.3A) None None STU  A 100 (-4.8A)	0.27A	22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	2eu9	DUAL SPECIFICITY PROTEIN KINASE CLK3 (Homo sapiens)	4 / 7	GLY A 163 GLY A 165 GLY A 168 VAL A 170	None	0.30A	23.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	2h8h	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC (Homo sapiens)	5 / 7	GLY A 274 GLY A 276 GLY A 279 VAL A 281 LEU A 297	H8H  A 534 ( 3.8A) None None H8H  A 534 (-4.4A) None	0.43A	22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	2hk5	TYROSINE-PROTEIN KINASE HCK (Homo sapiens)	4 / 7	GLY A 252 GLY A 254 GLY A 257 VAL A 259	None None None 1BM  A 499 ( 4.8A)	0.24A	23.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	2i0e	PROTEIN KINASE C-BETA II (Homo sapiens)	5 / 7	GLY A 349 GLY A 351 SER A 352 GLY A 354 LEU A 373	PDS  A 901 ( 3.7A) None None None None	1.32A	36.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	2jam	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE TYPE 1G (Homo sapiens)	4 / 7	GLY A  30 GLY A  32 PHE A  34 VAL A  37	None None None J60  A1305 (-4.8A)	0.26A	30.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	2og8	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK (Homo sapiens)	4 / 7	GLY A 252 GLY A 254 GLY A 257 VAL A 259	None	0.25A	23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	4 / 7	GLY A 589 GLY A 591 GLY A 594 VAL A 596	None	0.22A	25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	2r4b	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4 (Homo sapiens)	5 / 7	GLY A 725 GLY A 727 GLY A 730 VAL A 732 LEU A 753	None None None GW7  A   1 ( 4.8A) None	0.85A	24.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	2wtk	SERINE/THREONINE-PRO TEIN KINASE 11 (Homo sapiens)	5 / 7	GLY C  56 GLY C  58 SER C  59 GLY C  61 VAL C  63	ANP  C   2 (-3.3A) ANP  C   2 (-3.0A) None ANP  C   2 (-3.8A) ANP  C   2 (-4.2A)	0.69A	28.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	2xk9	CHECKPOINT KINASE 2 (Homo sapiens)	4 / 7	GLY A 227 GLY A 229 GLY A 232 VAL A 234	XK9  A1511 ( 4.5A) None None XK9  A1511 (-4.8A)	0.37A	34.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	2z8c	INSULIN RECEPTOR (Homo sapiens)	5 / 7	GLY A1003 GLY A1005 SER A1006 PHE A1007 GLY A1008	S91  A   1 ( 3.9A) None None None None	0.79A	23.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	3coi	MITOGEN-ACTIVATED PROTEIN KINASE 13 (Homo sapiens)	5 / 7	GLY A  32 GLY A  34 GLY A  37 VAL A  39 LEU A  56	None	0.81A	27.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	3hdn	SERINE/THREONINE-PRO TEIN KINASE SGK1 (Homo sapiens)	5 / 7	GLY A 105 GLY A 107 SER A 108 GLY A 110 LEU A 129	None GMG  A   1 (-3.3A) None None None	1.16A	38.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	3hng	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	4 / 7	GLY A 834 GLY A 836 GLY A 839 VAL A 841	None None None 8ST  A2001 ( 4.6A)	0.28A	23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	5 / 7	GLY A 697 GLY A 699 PHE A 701 GLY A 702 VAL A 704	ANP  A   1 (-3.7A) ANP  A   1 (-2.8A) None None ANP  A   1 (-3.9A)	0.56A	25.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 7	GLY A 695 GLY A 697 GLY A 700 VAL A 702 LEU A 723	ITI  A   1 ( 4.8A) None None ITI  A   1 (-4.8A) None	0.76A	22.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	3mvj	CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	5 / 7	GLY A  50 GLY A  52 GLY A  55 VAL A  57 LEU A  74	XFE  A 351 ( 4.0A) None None XFE  A 351 ( 4.5A) None	0.45A	94.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	3mvj	CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	5 / 7	GLY A  50 GLY A  52 SER A  53 GLY A  55 VAL A  57	XFE  A 351 ( 4.0A) None None None XFE  A 351 ( 4.5A)	0.54A	94.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	3mvj	CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	5 / 7	GLY A  50 GLY A  52 SER A  53 PHE A  54 GLY A  55	XFE  A 351 ( 4.0A) None None None None	1.00A	94.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	3my0	SERINE/THREONINE-PRO TEIN KINASE RECEPTOR R3 (Homo sapiens)	4 / 7	GLY A 209 GLY A 211 GLY A 214 VAL A 216	None None None LDN  A 600 (-4.5A)	0.33A	21.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	5 / 7	GLY A 157 GLY A 159 GLY A 162 VAL A 164 LEU A 181	GLY  A 157 ( 0.0A) GLY  A 159 ( 0.0A) GLY  A 162 ( 0.0A) VAL  A 164 ( 0.6A) LEU  A 181 ( 0.6A)	0.19A	34.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	3qfv	CDC42BPB PROTEIN (Homo sapiens)	4 / 7	GLY A  83 GLY A  88 VAL A  90 LEU A 107	NM7  A 416 (-3.0A) None NM7  A 416 (-3.7A) EDO  A 417 (-4.6A)	0.33A	33.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	3txo	PROTEIN KINASE C ETA TYPE (Homo sapiens)	6 / 7	GLY A 362 GLY A 364 SER A 365 GLY A 367 VAL A 369 LEU A 386	07U  A   1 ( 4.2A) None None None 07U  A   1 (-4.8A) None	0.80A	39.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	3vid	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	4 / 7	GLY A 841 GLY A 843 GLY A 846 VAL A 848	4TT  A2001 ( 4.8A) None None 4TT  A2001 ( 4.5A)	0.22A	22.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	3zdu	CYCLIN-DEPENDENT KINASE-LIKE 3 (Homo sapiens)	4 / 7	GLY A  11 GLY A  13 GLY A  16 VAL A  18	38R  A 350 ( 3.9A) None None 38R  A 350 ( 4.8A)	0.33A	31.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4agd	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	4 / 7	GLY A 841 GLY A 843 GLY A 846 VAL A 848	B49  A2000 ( 4.6A) None None None	0.29A	23.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4agu	CYCLIN-DEPENDENT KINASE-LIKE 1 (Homo sapiens)	4 / 7	GLY A  11 GLY A  13 GLY A  16 VAL A  18	D15  A 500 (-3.8A) D15  A 500 (-3.6A) D15  A 500 (-3.7A) D15  A 500 (-4.6A)	0.29A	24.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4c02	ACTIVIN RECEPTOR TYPE-1 (Homo sapiens)	4 / 7	GLY A 215 GLY A 217 GLY A 220 VAL A 222	None None None TAK  A1507 (-4.7A)	0.29A	21.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4f0i	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 7	GLY A 516 GLY A 518 GLY A 521 VAL A 523	None	0.25A	23.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4fr4	SERINE/THREONINE-PRO TEIN KINASE 32A (Homo sapiens)	5 / 7	GLY A  30 GLY A  32 SER A  33 GLY A  35 VAL A  37	STU  A 401 (-3.3A) None None None STU  A 401 ( 4.9A)	0.60A	29.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	4 / 7	GLY A 599 GLY A 601 GLY A 604 VAL A 606	None None None 924  A1101 ( 4.8A)	0.34A	24.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4gv1	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	5 / 7	GLY A 157 GLY A 159 GLY A 162 VAL A 164 LEU A 181	GOL  A 505 ( 3.4A) 0XZ  A 501 (-4.1A) 0XZ  A 501 (-3.8A) 0XZ  A 501 (-4.5A) GOL  A 503 (-4.9A)	0.29A	38.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4hvi	TYROSINE-PROTEIN KINASE JAK3 (Homo sapiens)	4 / 7	GLY A 829 GLY A 831 GLY A 834 VAL A 836	19S  A1201 (-3.7A) 19S  A1201 ( 4.3A) 19S  A1201 ( 4.9A) 19S  A1201 (-4.4A)	0.27A	24.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4idt	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14 (Homo sapiens)	4 / 7	GLY A 407 GLY A 409 SER A 410 GLY A 412	T28  A 701 ( 3.6A) T28  A 701 ( 3.0A) None None	0.31A	24.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4k11	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC (Homo sapiens)	5 / 7	GLY A 274 GLY A 276 GLY A 279 VAL A 281 LEU A 297	0J9  A 601 ( 4.0A) None None 0J9  A 601 (-4.4A) None	0.57A	22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4k33	FIBROBLAST GROWTH FACTOR RECEPTOR 3 (Homo sapiens)	4 / 7	GLY A 479 GLY A 481 GLY A 484 VAL A 486	ACP  A 801 (-3.4A) ACP  A 801 (-3.6A) ACP  A 801 (-3.6A) ACP  A 801 (-4.2A)	0.34A	25.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4ks8	SERINE/THREONINE-PRO TEIN KINASE PAK 6 (Homo sapiens)	5 / 7	GLY A 414 GLY A 416 SER A 417 GLY A 419 VAL A 421	B49  A 701 ( 4.3A) None None None None	0.71A	27.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4mk0	BETA-ADRENERGIC RECEPTOR KINASE 1 (Homo sapiens)	5 / 7	GLY A 198 GLY A 200 GLY A 203 VAL A 205 LEU A 222	29X  A 702 ( 4.1A) 29X  A 702 (-3.6A) 29X  A 702 (-3.5A) 29X  A 702 (-4.7A) None	0.40A	25.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4otd	SERINE/THREONINE-PRO TEIN KINASE N1 (Homo sapiens)	5 / 7	GLY A 628 GLY A 630 GLY A 633 VAL A 635 LEU A 652	None	0.78A	37.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4pwn	SERINE/THREONINE-PRO TEIN KINASE WNK1 (Homo sapiens)	5 / 7	GLY A 228 GLY A 230 SER A 231 PHE A 232 LEU A 252	None	0.79A	25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4pwn	SERINE/THREONINE-PRO TEIN KINASE WNK1 (Homo sapiens)	5 / 7	GLY A 228 GLY A 230 SER A 231 VAL A 235 LEU A 252	None	0.36A	25.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4q9z	HUMAN PROTEIN KINASE C THETA (Homo sapiens)	5 / 7	GLY A 387 GLY A 389 GLY A 392 VAL A 394 LEU A 411	PZW  A 801 ( 3.8A) None None PZW  A 801 (-4.6A) None	0.77A	37.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4q9z	HUMAN PROTEIN KINASE C THETA (Homo sapiens)	5 / 7	GLY A 387 GLY A 389 SER A 390 GLY A 392 LEU A 411	PZW  A 801 ( 3.8A) None None None None	1.06A	37.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4qtb	MITOGEN-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	4 / 7	GLY A  49 GLY A  51 GLY A  54 VAL A  56	None	0.37A	26.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4ra4	PROTEIN KINASE C (Homo sapiens)	6 / 7	GLY A 346 GLY A 348 SER A 349 GLY A 351 VAL A 353 LEU A 370	3KZ  A 701 (-3.3A) None None None 3KZ  A 701 (-3.9A) None	0.71A	36.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4rew	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-1 (Homo sapiens)	5 / 7	GLY A  25 GLY A  27 PHE A  29 GLY A  30 LEU A  49	STU  A 601 (-3.5A) STU  A 601 (-3.4A) None None None	1.06A	23.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4wb7	DNAJ HOMOLOG SUBFAMILY B MEMBER 1,CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	5 / 7	GLY A 105 GLY A 107 GLY A 110 VAL A 112 LEU A 129	ATP  A 501 (-3.5A) ATP  A 501 (-3.2A) ATP  A 501 (-3.8A) ATP  A 501 (-4.0A) None	0.62A	84.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4wb7	DNAJ HOMOLOG SUBFAMILY B MEMBER 1,CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	5 / 7	GLY A 105 GLY A 107 SER A 108 GLY A 110 VAL A 112	ATP  A 501 (-3.5A) ATP  A 501 (-3.2A) ATP  A 501 (-3.7A) ATP  A 501 (-3.8A) ATP  A 501 (-4.0A)	0.65A	84.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4xuf	RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 (Homo sapiens)	4 / 7	GLY A 617 GLY A 619 GLY A 622 VAL A 624	None None None P30  A1001 ( 4.8A)	0.17A	24.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4yff	SERINE/THREONINE-PRO TEIN KINASE TNNI3K (Homo sapiens)	4 / 7	GLY A 470 GLY A 472 GLY A 475 VAL A 477	4CV  A 801 ( 3.9A) None None None	0.36A	24.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4yk6	ADENOMATOUS POLYPOSIS COLI PROTEIN (Homo sapiens)	5 / 7	GLY A 618 GLY A 635 SER A 634 GLY A 636 VAL A 617	None	1.44A	21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4ylj	DUAL SPECIFICITY TYROSINE-PHOSPHORYLA TION-REGULATED KINASE 1A (Homo sapiens)	5 / 7	GLY A 166 GLY A 168 SER A 169 GLY A 171 VAL A 173	4E1  A 505 (-3.5A) 4E1  A 505 ( 4.9A) None None 4E1  A 505 (-4.5A)	0.61A	25.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	1gng	GLYCOGEN SYNTHASE KINASE-3 BETA (Homo sapiens)	5 / 7	GLY A  63 GLY A  65 SER A  66 VAL A  70 LYS A  85	None	0.72A	23.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	1gzk	RAC-BETA SERINE/THREONINE PROTEIN KINASE (Homo sapiens)	5 / 7	GLY A 159 GLY A 161 VAL A 166 LYS A 181 LEU A 183	None	0.32A	39.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	1tki	TITIN (Homo sapiens)	4 / 7	GLY A  31 GLY A  33 VAL A  38 LYS A  53	None	0.46A	25.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	1zrz	PROTEIN KINASE C, IOTA (Homo sapiens)	4 / 7	GLY A 252 GLY A 254 VAL A 259 LYS A 274	BI1  A1000 (-3.6A) None BI1  A1000 (-4.2A) BI1  A1000 (-3.5A)	0.37A	34.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	2a2a	DEATH-ASSOCIATED PROTEIN KINASE 2 (Homo sapiens)	4 / 7	GLY A  20 GLY A  22 VAL A  27 LYS A  42	None	0.33A	27.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	2eu9	DUAL SPECIFICITY PROTEIN KINASE CLK3 (Homo sapiens)	4 / 7	GLY A 163 GLY A 165 VAL A 170 LYS A 186	None	0.43A	23.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	2h8h	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC (Homo sapiens)	4 / 7	GLY A 274 GLY A 276 VAL A 281 LEU A 297	H8H  A 534 ( 3.8A) None H8H  A 534 (-4.4A) None	0.49A	22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	2hk5	TYROSINE-PROTEIN KINASE HCK (Homo sapiens)	4 / 7	GLY A 252 GLY A 254 VAL A 259 LYS A 273	None None 1BM  A 499 ( 4.8A) 1BM  A 499 (-3.8A)	0.46A	23.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	2hw6	MAP KINASE-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 1 (Homo sapiens)	4 / 7	GLY A  56 GLY A  58 VAL A  63 LYS A  78	None	0.29A	28.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	2hz0	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1 (Homo sapiens)	4 / 7	GLY A 249 GLY A 251 VAL A 256 LYS A 271	None None GIN  A 600 ( 4.7A) GIN  A 600 (-3.6A)	0.43A	24.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	2i0e	PROTEIN KINASE C-BETA II (Homo sapiens)	5 / 7	GLY A 349 GLY A 351 VAL A 356 LYS A 371 LEU A 373	PDS  A 901 ( 3.7A) None PDS  A 901 (-4.2A) PDS  A 901 ( 4.5A) None	0.75A	36.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	2jam	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE TYPE 1G (Homo sapiens)	5 / 7	GLY A  30 GLY A  32 PHE A  34 VAL A  37 LYS A  52	None None None J60  A1305 (-4.8A) EDO  A1304 ( 2.9A)	0.33A	30.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	2jc6	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE TYPE 1D (Homo sapiens)	4 / 7	GLY A  30 GLY A  32 VAL A  37 LYS A  52	QPP  A1314 ( 3.7A) None QPP  A1314 ( 4.6A) None	0.20A	31.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	2v55	RHO-ASSOCIATED PROTEIN KINASE 1 (Homo sapiens)	5 / 7	GLY A  83 GLY A  85 VAL A  90 LYS A 105 LEU A 107	ANP  A1480 ( 4.3A) ANP  A1480 ( 3.8A) None ANP  A1480 (-3.4A) None	0.47A	35.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	2vuw	SERINE/THREONINE-PRO TEIN KINASE HASPIN (Homo sapiens)	4 / 7	GLY A 491 GLY A 493 VAL A 498 LYS A 511	5ID  A1800 (-3.5A) None 5ID  A1800 ( 4.5A) IOD  A1799 (-3.2A)	0.45A	21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	2w4o	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE TYPE IV (Homo sapiens)	4 / 7	GLY A  53 GLY A  55 VAL A  60 LYS A  75	DKI  A1338 (-3.3A) None DKI  A1338 (-4.2A) None	0.31A	29.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	2wtk	SERINE/THREONINE-PRO TEIN KINASE 11 (Homo sapiens)	5 / 7	GLY C  56 GLY C  58 SER C  59 VAL C  63 LYS C  78	ANP  C   2 (-3.3A) ANP  C   2 (-3.0A) None ANP  C   2 (-4.2A) ANP  C   2 (-3.6A)	0.89A	28.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	4 / 7	GLY A  20 GLY A  22 VAL A  27 LYS A  42	4RB  A 401 (-3.6A) None 4RB  A 401 ( 4.4A) 4RB  A 401 ( 2.8A)	0.37A	26.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	4 / 7	GLY A  19 GLY A  21 VAL A  26 LYS A  41	None None 3AM  A 338 ( 4.1A) 3AM  A 338 (-2.9A)	0.22A	28.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	4 / 7	GLY A  33 GLY A  35 VAL A  40 LYS A  55	35F  A   1 ( 4.8A) None 35F  A   1 ( 4.8A) 35F  A   1 ( 4.6A)	0.32A	26.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3hng	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	4 / 7	GLY A 834 GLY A 836 VAL A 841 LYS A 861	None None 8ST  A2001 ( 4.6A) 8ST  A2001 (-4.0A)	0.48A	23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3lzb	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 7	GLY A 695 GLY A 697 VAL A 702 LYS A 721	ITI  A   1 ( 4.8A) None ITI  A   1 (-4.8A) ITI  A   1 (-2.6A)	0.44A	22.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3mvj	CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	5 / 7	GLY A  50 GLY A  52 SER A  53 VAL A  57 LYS A  72	XFE  A 351 ( 4.0A) None None XFE  A 351 ( 4.5A) None	0.69A	94.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3mvj	CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	5 / 7	GLY A  50 GLY A  52 VAL A  57 LYS A  72 LEU A  74	XFE  A 351 ( 4.0A) None XFE  A 351 ( 4.5A) None None	0.48A	94.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3my0	SERINE/THREONINE-PRO TEIN KINASE RECEPTOR R3 (Homo sapiens)	4 / 7	GLY A 209 GLY A 211 VAL A 216 LYS A 229	None None LDN  A 600 (-4.5A) LDN  A 600 (-4.0A)	0.35A	21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3nyo	G PROTEIN-COUPLED RECEPTOR KINASE 6 (Homo sapiens)	4 / 7	GLY A 193 VAL A 200 LYS A 215 LEU A 217	AMP  A 577 ( 3.7A) AMP  A 577 (-4.3A) AMP  A 577 (-2.8A) None	0.44A	26.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	5 / 7	GLY A 157 GLY A 159 VAL A 164 LYS A 179 LEU A 181	GLY  A 157 ( 0.0A) GLY  A 159 ( 0.0A) VAL  A 164 ( 0.6A) LYS  A 179 ( 0.0A) LEU  A 181 ( 0.6A)	0.38A	34.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3qfv	CDC42BPB PROTEIN (Homo sapiens)	4 / 7	GLY A  83 VAL A  90 LYS A 105 LEU A 107	NM7  A 416 (-3.0A) NM7  A 416 (-3.7A) EDO  A 417 (-3.5A) EDO  A 417 (-4.6A)	0.45A	33.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3txo	PROTEIN KINASE C ETA TYPE (Homo sapiens)	5 / 7	GLY A 362 GLY A 364 SER A 365 VAL A 369 LYS A 384	07U  A   1 ( 4.2A) None None 07U  A   1 (-4.8A) 07U  A   1 (-3.0A)	0.83A	39.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3txo	PROTEIN KINASE C ETA TYPE (Homo sapiens)	5 / 7	GLY A 362 GLY A 364 VAL A 369 LYS A 384 LEU A 386	07U  A   1 ( 4.2A) None 07U  A   1 (-4.8A) 07U  A   1 (-3.0A) None	0.46A	39.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3zdu	CYCLIN-DEPENDENT KINASE-LIKE 3 (Homo sapiens)	4 / 7	GLY A  11 GLY A  13 VAL A  18 LYS A  33	38R  A 350 ( 3.9A) None 38R  A 350 ( 4.8A) 38R  A 350 (-2.9A)	0.29A	31.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4agu	CYCLIN-DEPENDENT KINASE-LIKE 1 (Homo sapiens)	4 / 7	GLY A  11 GLY A  13 VAL A  18 LYS A  33	D15  A 500 (-3.8A) D15  A 500 (-3.6A) D15  A 500 (-4.6A) D15  A 500 ( 4.1A)	0.30A	24.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4c02	ACTIVIN RECEPTOR TYPE-1 (Homo sapiens)	4 / 7	GLY A 215 GLY A 217 VAL A 222 LYS A 235	None None TAK  A1507 (-4.7A) TAK  A1507 ( 4.5A)	0.34A	21.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4ckr	EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1 (Homo sapiens)	4 / 7	GLY A 617 GLY A 619 VAL A 624 LYS A 655	None None DI1  A1000 (-4.8A) DI1  A1000 (-3.9A)	0.31A	24.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4eut	SERINE/THREONINE-PRO TEIN KINASE TBK1 (Homo sapiens)	4 / 7	GLY A  16 GLY A  18 VAL A  23 LYS A  38	BX7  A 401 ( 3.7A) BX7  A 401 (-3.5A) BX7  A 401 (-4.4A) BX7  A 401 ( 4.0A)	0.38A	26.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4euu	SERINE/THREONINE-PRO TEIN KINASE TBK1 (Homo sapiens)	4 / 7	GLY A  16 GLY A  18 VAL A  23 LYS A  38	BX7  A 401 ( 3.8A) BX7  A 401 (-3.7A) BX7  A 401 ( 4.6A) BX7  A 401 (-3.5A)	0.32A	26.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	4 / 7	GLY A  65 GLY A  67 VAL A  72 LYS A  90	ADP  A 601 ( 3.8A) ADP  A 601 (-3.7A) ADP  A 601 (-4.0A) ADP  A 601 (-2.6A)	0.35A	26.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4gv1	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	5 / 7	GLY A 157 GLY A 159 VAL A 164 LYS A 179 LEU A 181	GOL  A 505 ( 3.4A) 0XZ  A 501 (-4.1A) 0XZ  A 501 (-4.5A) GOL  A 503 ( 2.8A) GOL  A 503 (-4.9A)	0.39A	38.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4k33	FIBROBLAST GROWTH FACTOR RECEPTOR 3 (Homo sapiens)	4 / 7	GLY A 479 GLY A 481 VAL A 486 LYS A 508	ACP  A 801 (-3.4A) ACP  A 801 (-3.6A) ACP  A 801 (-4.2A) ACP  A 801 (-2.7A)	0.31A	25.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4mk0	BETA-ADRENERGIC RECEPTOR KINASE 1 (Homo sapiens)	5 / 7	GLY A 198 GLY A 200 VAL A 205 LYS A 220 LEU A 222	29X  A 702 ( 4.1A) 29X  A 702 (-3.6A) 29X  A 702 (-4.7A) 29X  A 702 (-3.6A) None	0.52A	25.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4otd	SERINE/THREONINE-PRO TEIN KINASE N1 (Homo sapiens)	4 / 7	GLY A 628 GLY A 630 VAL A 635 LEU A 652	None	0.42A	37.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4pwn	SERINE/THREONINE-PRO TEIN KINASE WNK1 (Homo sapiens)	5 / 7	GLY A 228 GLY A 230 SER A 231 VAL A 235 LEU A 252	None	0.41A	25.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4q9z	HUMAN PROTEIN KINASE C THETA (Homo sapiens)	5 / 7	GLY A 387 GLY A 389 SER A 390 LYS A 409 LEU A 411	PZW  A 801 ( 3.8A) None None None None	1.10A	37.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4q9z	HUMAN PROTEIN KINASE C THETA (Homo sapiens)	5 / 7	GLY A 387 GLY A 389 VAL A 394 LYS A 409 LEU A 411	PZW  A 801 ( 3.8A) None PZW  A 801 (-4.6A) None None	0.54A	37.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4ra4	PROTEIN KINASE C (Homo sapiens)	5 / 7	GLY A 346 GLY A 348 SER A 349 VAL A 353 LEU A 370	3KZ  A 701 (-3.3A) None None 3KZ  A 701 (-3.9A) None	0.71A	36.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4ra4	PROTEIN KINASE C (Homo sapiens)	5 / 7	GLY A 346 SER A 349 VAL A 353 LYS A 368 LEU A 370	3KZ  A 701 (-3.3A) None 3KZ  A 701 (-3.9A) 3KZ  A 701 ( 4.7A) None	0.70A	36.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4rew	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-1 (Homo sapiens)	5 / 7	GLY A  25 PHE A  29 VAL A  32 LYS A  47 LEU A  49	STU  A 601 (-3.5A) None STU  A 601 ( 4.8A) STU  A 601 ( 3.7A) None	1.13A	23.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4tnb	G PROTEIN-COUPLED RECEPTOR KINASE 5 (Homo sapiens)	4 / 7	GLY A 193 VAL A 200 LYS A 215 LEU A 217	SGV  A 601 (-3.4A) SGV  A 601 ( 4.6A) SGV  A 601 ( 4.2A) None	0.48A	26.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4wb7	DNAJ HOMOLOG SUBFAMILY B MEMBER 1,CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	4 / 7	GLY A 105 GLY A 107 VAL A 112 LEU A 129	ATP  A 501 (-3.5A) ATP  A 501 (-3.2A) ATP  A 501 (-4.0A) None	0.47A	84.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4wb7	DNAJ HOMOLOG SUBFAMILY B MEMBER 1,CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	4 / 7	GLY A 105 VAL A 112 LYS A 127 LEU A 129	ATP  A 501 (-3.5A) ATP  A 501 (-4.0A) ATP  A 501 (-2.6A) None	0.27A	84.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4xuf	RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 (Homo sapiens)	4 / 7	GLY A 617 GLY A 619 VAL A 624 LYS A 644	None None P30  A1001 ( 4.8A) P30  A1001 ( 4.0A)	0.48A	24.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4yff	SERINE/THREONINE-PRO TEIN KINASE TNNI3K (Homo sapiens)	4 / 7	GLY A 470 GLY A 472 VAL A 477 LYS A 490	4CV  A 801 ( 3.9A) None None 4CV  A 801 (-3.9A)	0.36A	24.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4ylj	DUAL SPECIFICITY TYROSINE-PHOSPHORYLA TION-REGULATED KINASE 1A (Homo sapiens)	4 / 7	GLY A 166 GLY A 168 SER A 169 VAL A 173	4E1  A 505 (-3.5A) 4E1  A 505 ( 4.9A) None 4E1  A 505 (-4.5A)	0.41A	25.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	5es1	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 4 (Homo sapiens)	4 / 7	GLY A  63 GLY A  65 VAL A  70 LYS A  85	5RC  A4000 ( 4.3A) 5RC  A4000 ( 3.9A) 5RC  A4000 (-4.6A) 5RC  A4000 (-2.8A)	0.34A	32.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	5fd2	SERINE/THREONINE-PRO TEIN KINASE B-RAF (Homo sapiens)	4 / 7	GLY A 464 GLY A 466 VAL A 471 LYS A 483	None None 5XJ  A 801 (-4.6A) 5XJ  A 801 (-3.8A)	0.27A	25.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	5fm2	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	4 / 7	GLY A 731 GLY A 733 VAL A 738 LYS A 758	PP1  A2012 ( 3.9A) None PP1  A2012 (-4.4A) PP1  A2012 (-4.1A)	0.47A	26.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	5idn	CYCLIN-DEPENDENT KINASE 8 (Homo sapiens)	4 / 7	GLY A  28 GLY A  30 VAL A  35 LYS A  52	6A7  A 401 (-3.6A) None 6A7  A 401 ( 4.5A) 6A7  A 401 ( 2.9A)	0.48A	25.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	5j9z	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 7	GLY A 719 GLY A 721 VAL A 726 LYS A 745	6HJ  A1101 ( 4.2A) None 6HJ  A1101 ( 4.7A) 6HJ  A1101 (-4.2A)	0.48A	24.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	5lxd	DUAL SPECIFICITY TYROSINE-PHOSPHORYLA TION-REGULATED KINASE 2 (Homo sapiens)	5 / 7	GLY A 156 GLY A 158 SER A 159 VAL A 163 LYS A 178	7A7  A 501 (-3.2A) None None 7A7  A 501 (-4.4A) 7A7  A 501 (-3.5A)	0.68A	26.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	5o2c	SERINE/THREONINE-PRO TEIN KINASE WNK3 (Homo sapiens)	4 / 7	GLY A 154 GLY A 156 VAL A 161 LEU A 178	None	0.45A	26.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	5tur	SERINE/THREONINE-PRO TEIN KINASE PIM-1 (Homo sapiens)	4 / 7	GLY A  45 GLY A  47 VAL A  52 LYS A  67	None None 7LK  A 401 (-4.9A) None	0.46A	23.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	5u7q	RHO-ASSOCIATED PROTEIN KINASE 2 (Homo sapiens)	5 / 7	GLY A  99 GLY A 101 VAL A 106 LYS A 121 LEU A 123	None	0.41A	34.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	5uuu	BETA-ADRENERGIC RECEPTOR KINASE 1 (Homo sapiens)	5 / 7	GLY A 198 GLY A 200 VAL A 205 LYS A 220 LEU A 222	QRW  A 601 ( 4.5A) QRW  A 601 (-3.6A) QRW  A 601 (-4.7A) QRW  A 601 (-3.0A) QRW  A 601 (-4.3A)	0.63A	26.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	5vcx	MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE (Homo sapiens)	5 / 7	GLY A 117 GLY A 119 SER A 120 VAL A 124 LYS A 139	H8H  A 401 ( 3.7A) None None H8H  A 401 (-4.7A) H8H  A 401 (-4.9A)	0.80A	26.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	5y86	DUAL SPECIFICITY TYROSINE-PHOSPHORYLA TION-REGULATED KINASE 3 (Homo sapiens)	5 / 7	GLY A 216 GLY A 218 SER A 219 VAL A 223 LYS A 238	None PO4  A 602 (-3.5A) PO4  A 602 (-2.7A) HRM  A 601 ( 4.9A) HRM  A 601 (-3.3A)	0.65A	12.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	6b4w	DUAL SPECIFICITY PROTEIN KINASE TTK (Homo sapiens)	4 / 7	GLY A 532 GLY A 534 VAL A 539 LYS A 553	CQ7  A 801 ( 4.0A) None CQ7  A 801 ( 4.8A) CQ7  A 801 (-3.2A)	0.39A	24.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	6bfn	INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 1 (Homo sapiens)	5 / 7	GLY A 219 GLY A 221 VAL A 226 LYS A 239 LEU A 241	DL1  A 601 ( 4.1A) None None DL1  A 601 ( 4.1A) None	0.69A	11.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	6bql	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 2 (Homo sapiens)	6 / 7	GLY A 172 GLY A 174 SER A 175 VAL A 179 LYS A 194 LEU A 196	BI9  A 501 (-3.6A) None ACT  A 504 (-3.3A) BI9  A 501 ( 4.8A) NH4  A 506 ( 4.4A) None	0.60A	13.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	6c0t	CGMP-DEPENDENT PROTEIN KINASE 1 (Homo sapiens)	6 / 7	GLY A 367 GLY A 369 PHE A 371 VAL A 374 LYS A 390 LEU A 392	EE4  A 701 (-3.9A) EE4  A 701 (-3.4A) EE4  A 701 (-3.0A) EE4  A 701 (-4.4A) DMS  A 702 (-3.5A) EE4  A 701 ( 4.6A)	0.51A	18.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 7	GLY A  67 GLY A  69 PHE A  71 VAL A  74 LYS A  89	None	0.71A	13.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	5 / 7	GLY A 135 GLY A 137 VAL A 142 LYS A 157 LEU A 159	H1N  A 501 ( 3.8A) None H1N  A 501 (-4.4A) H1N  A 501 (-2.8A) None	0.44A	13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	6fyl	DUAL SPECIFICITY PROTEIN KINASE CLK2 (Homo sapiens)	4 / 7	GLY A 170 GLY A 172 VAL A 177 LYS A 193	3NG  A 501 (-3.5A) 3NG  A 501 ( 4.5A) 3NG  A 501 ( 4.4A) 3NG  A 501 (-3.0A)	0.46A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	6fyv	DUAL SPECIFICITY PROTEIN KINASE CLK4 (Homo sapiens)	4 / 7	GLY A 168 GLY A 170 VAL A 175 LYS A 191	3NG  A 501 (-3.5A) 3NG  A 501 ( 4.9A) 3NG  A 501 ( 4.3A) 3NG  A 501 (-2.7A)	0.34A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	1gng	GLYCOGEN SYNTHASE KINASE-3 BETA (Homo sapiens)	6 / 7	GLY A  63 GLY A  65 SER A  66 VAL A  70 LYS A  85 ASP A 200	None	0.56A	23.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	1gzk	RAC-BETA SERINE/THREONINE PROTEIN KINASE (Homo sapiens)	4 / 7	GLY A 159 GLY A 161 VAL A 166 LYS A 181	None	0.37A	39.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	1nxk	MAP KINASE-ACTIVATED PROTEIN KINASE 2 (Homo sapiens)	4 / 7	GLY A  71 VAL A  78 LYS A  93 ASP A 207	STU  A 401 (-3.6A) STU  A 401 (-4.7A) STU  A 401 ( 4.5A) STU  A 401 (-3.6A)	0.42A	28.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	1tki	TITIN (Homo sapiens)	4 / 7	GLY A  31 GLY A  33 VAL A  38 LYS A  53	None	0.39A	25.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	1u59	TYROSINE-PROTEIN KINASE ZAP-70 (Homo sapiens)	4 / 7	GLY A 345 GLY A 347 VAL A 352 ASP A 479	STU  A 100 (-3.3A) None STU  A 100 (-4.8A) STU  A 100 (-3.5A)	0.38A	22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	1u59	TYROSINE-PROTEIN KINASE ZAP-70 (Homo sapiens)	4 / 7	GLY A 345 GLY A 347 VAL A 352 LYS A 369	STU  A 100 (-3.3A) None STU  A 100 (-4.8A) STU  A 100 ( 4.7A)	0.39A	22.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	1zrz	PROTEIN KINASE C, IOTA (Homo sapiens)	4 / 7	GLY A 252 GLY A 254 VAL A 259 LYS A 274	BI1  A1000 (-3.6A) None BI1  A1000 (-4.2A) BI1  A1000 (-3.5A)	0.30A	34.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	2a1a	INTERFERON-INDUCED, DOUBLE-STRANDED RNA-ACTIVATED PROTEIN KINASE (Homo sapiens)	5 / 7	GLY B 274 GLY B 276 VAL B 281 LYS B 296 ASP B 432	None	0.71A	25.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	2a2a	DEATH-ASSOCIATED PROTEIN KINASE 2 (Homo sapiens)	4 / 7	GLY A  20 GLY A  22 VAL A  27 LYS A  42	None	0.42A	27.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	2dq7	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FYN (Homo sapiens)	4 / 7	GLY X  18 VAL X  25 LYS X  39 ASP X 148	STU  X 902 ( 3.7A) STU  X 902 ( 4.8A) STU  X 902 (-3.1A) STU  X 902 (-3.6A)	0.35A	23.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	2eu9	DUAL SPECIFICITY PROTEIN KINASE CLK3 (Homo sapiens)	5 / 7	GLY A 163 GLY A 165 VAL A 170 LYS A 186 ASP A 320	None	0.64A	23.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	2hk5	TYROSINE-PROTEIN KINASE HCK (Homo sapiens)	4 / 7	GLY A 252 GLY A 254 VAL A 259 LYS A 273	None None 1BM  A 499 ( 4.8A) 1BM  A 499 (-3.8A)	0.39A	23.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	2hw6	MAP KINASE-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 1 (Homo sapiens)	4 / 7	GLY A  56 GLY A  58 VAL A  63 LYS A  78	None	0.28A	28.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	2hz0	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1 (Homo sapiens)	4 / 7	GLY A 249 GLY A 251 VAL A 256 LYS A 271	None None GIN  A 600 ( 4.7A) GIN  A 600 (-3.6A)	0.48A	24.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	2iwi	SERINE/THREONINE-PRO TEIN KINASE PIM-2 (Homo sapiens)	4 / 7	GLY A  39 GLY A  41 VAL A  46 ASP A 182	HB1  A1289 (-3.1A) None HB1  A1289 (-3.6A) HB1  A1289 (-4.2A)	0.45A	24.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	2jam	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE TYPE 1G (Homo sapiens)	4 / 7	GLY A  30 GLY A  32 VAL A  37 LYS A  52	None None J60  A1305 (-4.8A) EDO  A1304 ( 2.9A)	0.31A	30.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	2jc6	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE TYPE 1D (Homo sapiens)	4 / 7	GLY A  30 GLY A  32 VAL A  37 LYS A  52	QPP  A1314 ( 3.7A) None QPP  A1314 ( 4.6A) None	0.30A	31.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	2v55	RHO-ASSOCIATED PROTEIN KINASE 1 (Homo sapiens)	4 / 7	GLY A  83 GLY A  85 VAL A  90 LYS A 105	ANP  A1480 ( 4.3A) ANP  A1480 ( 3.8A) None ANP  A1480 (-3.4A)	0.41A	35.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	2w4o	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE TYPE IV (Homo sapiens)	4 / 7	GLY A  53 GLY A  55 VAL A  60 LYS A  75	DKI  A1338 (-3.3A) None DKI  A1338 (-4.2A) None	0.35A	29.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	2wtk	SERINE/THREONINE-PRO TEIN KINASE 11 (Homo sapiens)	5 / 7	GLY C  56 GLY C  58 SER C  59 VAL C  63 LYS C  78	ANP  C   2 (-3.3A) ANP  C   2 (-3.0A) None ANP  C   2 (-4.2A) ANP  C   2 (-3.6A)	0.79A	28.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	2z2w	WEE1-LIKE PROTEIN KINASE (Homo sapiens)	4 / 7	GLY A 306 GLY A 308 VAL A 313 ASP A 463	770  A 901 ( 4.6A) None 770  A 901 ( 4.7A) 770  A 901 (-3.8A)	0.48A	23.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 7	GLY A  20 GLY A  22 VAL A  27 LYS A  42 ASP A 161	4RB  A 401 (-3.6A) None 4RB  A 401 ( 4.4A) 4RB  A 401 ( 2.8A) GOL  A 503 ( 3.1A)	0.78A	26.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	4 / 7	GLY A  19 GLY A  21 VAL A  26 LYS A  41	None None 3AM  A 338 ( 4.1A) 3AM  A 338 (-2.9A)	0.25A	28.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3d7u	TYROSINE-PROTEIN KINASE CSK (Homo sapiens)	5 / 7	GLY A 202 GLY A 204 VAL A 209 LYS A 222 ASP A 332	None	0.76A	23.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	4 / 7	GLY A  33 GLY A  35 VAL A  40 LYS A  55	35F  A   1 ( 4.8A) None 35F  A   1 ( 4.8A) 35F  A   1 ( 4.6A)	0.33A	26.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3mdy	BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE-1B (Homo sapiens)	4 / 7	GLY A 211 VAL A 218 LYS A 231 ASP A 350	LDN  A   1 ( 4.7A) LDN  A   1 ( 4.8A) None LDN  A   1 (-3.9A)	0.41A	21.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3mvj	CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	5 / 7	GLY A  50 GLY A  52 SER A  53 VAL A  57 LYS A  72	XFE  A 351 ( 4.0A) None None XFE  A 351 ( 4.5A) None	0.70A	94.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3mvj	CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	4 / 7	GLY A  50 VAL A  57 LYS A  72 ASP A 184	XFE  A 351 ( 4.0A) XFE  A 351 ( 4.5A) None None	0.39A	94.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3my0	SERINE/THREONINE-PRO TEIN KINASE RECEPTOR R3 (Homo sapiens)	4 / 7	GLY A 209 GLY A 211 VAL A 216 LYS A 229	None None LDN  A 600 (-4.5A) LDN  A 600 (-4.0A)	0.25A	21.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 7	GLY A 157 GLY A 159 VAL A 164 LYS A 179	GLY  A 157 ( 0.0A) GLY  A 159 ( 0.0A) VAL  A 164 ( 0.6A) LYS  A 179 ( 0.0A)	0.41A	34.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3pp0	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2 (Homo sapiens)	4 / 7	GLY A 727 VAL A 734 LYS A 753 ASP A 863	None 03Q  A   1 (-4.5A) 03Q  A   1 (-4.7A) 03Q  A   1 (-4.0A)	0.45A	23.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3txo	PROTEIN KINASE C ETA TYPE (Homo sapiens)	5 / 7	GLY A 362 GLY A 364 SER A 365 VAL A 369 LYS A 384	07U  A   1 ( 4.2A) None None 07U  A   1 (-4.8A) 07U  A   1 (-3.0A)	0.72A	39.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3txo	PROTEIN KINASE C ETA TYPE (Homo sapiens)	5 / 7	GLY A 362 GLY A 364 VAL A 369 LYS A 384 ASP A 497	07U  A   1 ( 4.2A) None 07U  A   1 (-4.8A) 07U  A   1 (-3.0A) 07U  A   1 (-3.6A)	0.58A	39.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3vid	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	4 / 7	GLY A 841 GLY A 843 VAL A 848 LYS A 868	4TT  A2001 ( 4.8A) None 4TT  A2001 ( 4.5A) None	0.44A	22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3vn9	DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 6 (Homo sapiens)	5 / 7	GLY A  60 GLY A  62 VAL A  67 LYS A  82 ASP A 197	ANK  A 401 (-3.4A) ANK  A 401 ( 4.9A) ANK  A 401 (-4.3A) ANK  A 401 (-2.4A) MG  A 402 ( 2.8A)	1.04A	26.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3zdu	CYCLIN-DEPENDENT KINASE-LIKE 3 (Homo sapiens)	5 / 7	GLY A  11 GLY A  13 VAL A  18 LYS A  33 ASP A 143	38R  A 350 ( 3.9A) None 38R  A 350 ( 4.8A) 38R  A 350 (-2.9A) NA  A 353 ( 2.5A)	0.54A	31.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4agu	CYCLIN-DEPENDENT KINASE-LIKE 1 (Homo sapiens)	4 / 7	GLY A  11 GLY A  13 VAL A  18 LYS A  33	D15  A 500 (-3.8A) D15  A 500 (-3.6A) D15  A 500 (-4.6A) D15  A 500 ( 4.1A)	0.41A	24.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4bgq	CYCLIN-DEPENDENT KINASE-LIKE 5 (Homo sapiens)	4 / 7	GLY A  20 GLY A  22 VAL A  27 LYS A  42	None None 38R  A1000 ( 4.8A) 38R  A1000 (-3.4A)	0.44A	25.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4c02	ACTIVIN RECEPTOR TYPE-1 (Homo sapiens)	5 / 7	GLY A 215 GLY A 217 VAL A 222 LYS A 235 ASP A 354	None None TAK  A1507 (-4.7A) TAK  A1507 ( 4.5A) TAK  A1507 (-3.5A)	0.82A	21.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4ckr	EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1 (Homo sapiens)	4 / 7	GLY A 617 GLY A 619 VAL A 624 LYS A 655	None None DI1  A1000 (-4.8A) DI1  A1000 (-3.9A)	0.33A	24.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4euu	SERINE/THREONINE-PRO TEIN KINASE TBK1 (Homo sapiens)	4 / 7	GLY A  16 GLY A  18 VAL A  23 LYS A  38	BX7  A 401 ( 3.8A) BX7  A 401 (-3.7A) BX7  A 401 ( 4.6A) BX7  A 401 (-3.5A)	0.42A	26.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4f99	CELL DIVISION CYCLE 7-RELATED PROTEIN KINASE (Homo sapiens)	4 / 7	GLY A  65 GLY A  67 VAL A  72 LYS A  90	ADP  A 601 ( 3.8A) ADP  A 601 (-3.7A) ADP  A 601 (-4.0A) ADP  A 601 (-2.6A)	0.39A	26.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4fr4	SERINE/THREONINE-PRO TEIN KINASE 32A (Homo sapiens)	4 / 7	GLY A  30 GLY A  32 SER A  33 ASP A 164	STU  A 401 (-3.3A) None None STU  A 401 ( 3.9A)	0.48A	29.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4gv1	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	5 / 7	GLY A 157 GLY A 159 VAL A 164 LYS A 179 ASP A 292	GOL  A 505 ( 3.4A) 0XZ  A 501 (-4.1A) 0XZ  A 501 (-4.5A) GOL  A 503 ( 2.8A) 0XZ  A 501 ( 3.4A)	0.66A	38.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4k33	FIBROBLAST GROWTH FACTOR RECEPTOR 3 (Homo sapiens)	5 / 7	GLY A 479 GLY A 481 VAL A 486 LYS A 508 ASP A 635	ACP  A 801 (-3.4A) ACP  A 801 (-3.6A) ACP  A 801 (-4.2A) ACP  A 801 (-2.7A) MG  A 802 ( 3.0A)	0.69A	25.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4otd	SERINE/THREONINE-PRO TEIN KINASE N1 (Homo sapiens)	5 / 7	GLY A 628 GLY A 630 VAL A 635 LYS A 650 ASP A 764	None	0.64A	37.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4pwn	SERINE/THREONINE-PRO TEIN KINASE WNK1 (Homo sapiens)	5 / 7	GLY A 228 GLY A 230 SER A 231 PHE A 232 VAL A 235	None	0.59A	25.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4q9z	HUMAN PROTEIN KINASE C THETA (Homo sapiens)	5 / 7	GLY A 387 GLY A 389 SER A 390 VAL A 394 LYS A 409	PZW  A 801 ( 3.8A) None None PZW  A 801 (-4.6A) None	0.82A	37.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4ra4	PROTEIN KINASE C (Homo sapiens)	5 / 7	GLY A 346 GLY A 348 SER A 349 VAL A 353 LYS A 368	3KZ  A 701 (-3.3A) None None 3KZ  A 701 (-3.9A) 3KZ  A 701 ( 4.7A)	0.64A	36.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4rew	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-1 (Homo sapiens)	4 / 7	GLY A  25 VAL A  32 LYS A  47 ASP A 159	STU  A 601 (-3.5A) STU  A 601 ( 4.8A) STU  A 601 ( 3.7A) STU  A 601 (-3.7A)	0.46A	23.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4wb7	DNAJ HOMOLOG SUBFAMILY B MEMBER 1,CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	4 / 7	GLY A 105 VAL A 112 LYS A 127 ASP A 239	ATP  A 501 (-3.5A) ATP  A 501 (-4.0A) ATP  A 501 (-2.6A) ZN  A 503 (-1.9A)	0.43A	84.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4xuf	RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 (Homo sapiens)	4 / 7	GLY A 617 GLY A 619 VAL A 624 LYS A 644	None None P30  A1001 ( 4.8A) P30  A1001 ( 4.0A)	0.42A	24.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4yff	SERINE/THREONINE-PRO TEIN KINASE TNNI3K (Homo sapiens)	5 / 7	GLY A 470 GLY A 472 VAL A 477 LYS A 490 ASP A 606	4CV  A 801 ( 3.9A) None None 4CV  A 801 (-3.9A) 4CV  A 801 (-3.5A)	0.48A	24.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4ylj	DUAL SPECIFICITY TYROSINE-PHOSPHORYLA TION-REGULATED KINASE 1A (Homo sapiens)	5 / 7	GLY A 166 GLY A 168 SER A 169 VAL A 173 LYS A 188	4E1  A 505 (-3.5A) 4E1  A 505 ( 4.9A) None 4E1  A 505 (-4.5A) 4E1  A 505 (-2.7A)	0.55A	25.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	5es1	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 4 (Homo sapiens)	5 / 7	GLY A  63 GLY A  65 VAL A  70 LYS A  85 ASP A 196	5RC  A4000 ( 4.3A) 5RC  A4000 ( 3.9A) 5RC  A4000 (-4.6A) 5RC  A4000 (-2.8A) 5RC  A4000 (-3.6A)	0.57A	32.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	5fd2	SERINE/THREONINE-PRO TEIN KINASE B-RAF (Homo sapiens)	5 / 7	GLY A 464 GLY A 466 VAL A 471 LYS A 483 ASP A 594	None None 5XJ  A 801 (-4.6A) 5XJ  A 801 (-3.8A) None	0.52A	25.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	5fm2	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	4 / 7	GLY A 731 GLY A 733 VAL A 738 LYS A 758	PP1  A2012 ( 3.9A) None PP1  A2012 (-4.4A) PP1  A2012 (-4.1A)	0.44A	26.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	5idn	CYCLIN-DEPENDENT KINASE 8 (Homo sapiens)	4 / 7	GLY A  28 GLY A  30 VAL A  35 LYS A  52	6A7  A 401 (-3.6A) None 6A7  A 401 ( 4.5A) 6A7  A 401 ( 2.9A)	0.40A	25.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	5j5t	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 3 (Homo sapiens)	4 / 7	GLY A  23 VAL A  30 LYS A  45 ASP A 154	None 6G2  A 901 ( 4.9A) 6G2  A 901 ( 3.9A) 6G2  A 901 (-3.4A)	0.39A	25.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	5j9z	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 7	GLY A 719 GLY A 721 VAL A 726 LYS A 745	6HJ  A1101 ( 4.2A) None 6HJ  A1101 ( 4.7A) 6HJ  A1101 (-4.2A)	0.41A	24.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	5lxd	DUAL SPECIFICITY TYROSINE-PHOSPHORYLA TION-REGULATED KINASE 2 (Homo sapiens)	5 / 7	GLY A 156 GLY A 158 SER A 159 VAL A 163 LYS A 178	7A7  A 501 (-3.2A) None None 7A7  A 501 (-4.4A) 7A7  A 501 (-3.5A)	0.63A	26.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	5lxd	DUAL SPECIFICITY TYROSINE-PHOSPHORYLA TION-REGULATED KINASE 2 (Homo sapiens)	5 / 7	GLY A 156 GLY A 158 VAL A 163 LYS A 178 ASP A 295	7A7  A 501 (-3.2A) None 7A7  A 501 (-4.4A) 7A7  A 501 (-3.5A) 7A7  A 501 (-3.2A)	0.51A	26.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	5tur	SERINE/THREONINE-PRO TEIN KINASE PIM-1 (Homo sapiens)	5 / 7	GLY A  45 GLY A  47 VAL A  52 LYS A  67 ASP A 186	None None 7LK  A 401 (-4.9A) None None	0.85A	23.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	5u7q	RHO-ASSOCIATED PROTEIN KINASE 2 (Homo sapiens)	5 / 7	GLY A  99 GLY A 101 VAL A 106 LYS A 121 ASP A 232	None	0.85A	34.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	5vcx	MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE (Homo sapiens)	5 / 7	GLY A 117 GLY A 119 SER A 120 VAL A 124 LYS A 139	H8H  A 401 ( 3.7A) None None H8H  A 401 (-4.7A) H8H  A 401 (-4.9A)	0.66A	26.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	5xv7	SERINE-ARGININE (SR) PROTEIN KINASE 1 (Homo sapiens)	4 / 7	GLY A  87 GLY A  89 VAL A  94 LYS A 109	EMH  A 705 ( 3.9A) None EMH  A 705 ( 4.4A) EMH  A 705 ( 4.8A)	0.49A	10.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	5y86	DUAL SPECIFICITY TYROSINE-PHOSPHORYLA TION-REGULATED KINASE 3 (Homo sapiens)	5 / 7	GLY A 216 GLY A 218 VAL A 223 LYS A 238 ASP A 355	None PO4  A 602 (-3.5A) HRM  A 601 ( 4.9A) HRM  A 601 (-3.3A) HRM  A 601 (-4.7A)	0.72A	12.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	6b4w	DUAL SPECIFICITY PROTEIN KINASE TTK (Homo sapiens)	4 / 7	GLY A 532 GLY A 534 VAL A 539 LYS A 553	CQ7  A 801 ( 4.0A) None CQ7  A 801 ( 4.8A) CQ7  A 801 (-3.2A)	0.43A	24.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	6bql	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 2 (Homo sapiens)	5 / 7	GLY A 172 GLY A 174 SER A 175 VAL A 179 LYS A 194	BI9  A 501 (-3.6A) None ACT  A 504 (-3.3A) BI9  A 501 ( 4.8A) NH4  A 506 ( 4.4A)	0.46A	13.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	6c0t	CGMP-DEPENDENT PROTEIN KINASE 1 (Homo sapiens)	4 / 7	GLY A 367 GLY A 369 VAL A 374 LYS A 390	EE4  A 701 (-3.9A) EE4  A 701 (-3.4A) EE4  A 701 (-4.4A) DMS  A 702 (-3.5A)	0.29A	18.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 7	GLY A  67 GLY A  69 PHE A  71 VAL A  74 LYS A  89	None	0.69A	13.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 7	GLY A  67 GLY A  69 VAL A  74 LYS A  89 ASP A 200	None	0.51A	13.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	5 / 7	GLY A 135 GLY A 137 VAL A 142 LYS A 157 ASP A 293	H1N  A 501 ( 3.8A) None H1N  A 501 (-4.4A) H1N  A 501 (-2.8A) H1N  A 501 (-3.5A)	0.78A	13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	6fyl	DUAL SPECIFICITY PROTEIN KINASE CLK2 (Homo sapiens)	4 / 7	GLY A 170 GLY A 172 VAL A 177 LYS A 193	3NG  A 501 (-3.5A) 3NG  A 501 ( 4.5A) 3NG  A 501 ( 4.4A) 3NG  A 501 (-3.0A)	0.34A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	6fyo	DUAL SPECIFICITY PROTEIN KINASE CLK1 (Homo sapiens)	5 / 7	GLY A 168 GLY A 170 VAL A 175 LYS A 191 ASP A 325	None None None EAQ  A 501 (-3.2A) EAQ  A 501 (-4.6A)	0.70A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	6fyv	DUAL SPECIFICITY PROTEIN KINASE CLK4 (Homo sapiens)	5 / 7	GLY A 168 GLY A 170 VAL A 175 LYS A 191 ASP A 325	3NG  A 501 (-3.5A) 3NG  A 501 ( 4.9A) 3NG  A 501 ( 4.3A) 3NG  A 501 (-2.7A) 3NG  A 501 (-4.3A)	0.68A	undetectable